18 September 2020
LEI No. 213800QIPVTK5ES5UU36
SCAPA GROUP PLC
('the Company')
Director/PDMR Notification
Notification and public disclosure of transactions by persons discharging managerial responsibilities ('PDMR')
Scapa Group plc (AIM: SCPA) today announces that on 16 September 2020, the PDMRs named below were each granted nil cost options, under the Scapa Group plc 2019 Long Term Incentive Plan ('LTIP'), in respect of the number of ordinary shares of 5p each ('Ordinary Shares') shown alongside their respective names.
| Name / Position of PDMR |
Number of Ordinary Shares over which the option is held |
| Oskar Zahn - Chief Financial Officer |
300,172 |
| John Petreanu - President Healthcare |
254,113 |
| Brett Pollard - MD Global Corporate Dev & Strategy |
75,043 |
| Wendy Baker - Group General Counsel and CoSec |
145,798 |
In accordance with the rules of the LTIP, no consideration was paid by the above-named individuals for the option granted to him/her. Each option is subject to, and governed by, the rules of the LTIP and the legislation relating to the LTIP.
This announcement, including the notifications below, is made in accordance with the requirements of the EU Market Abuse Regulation.
ANNEX
| 1 |
Details of the person discharging managerial responsibilities / person closely associated
|
|
| a) |
Name |
Oskar Zahn
|
| 2 |
Reason for the notification
|
|
| a) |
Position / status |
Chief Financial Officer
|
| b) |
Initial notification / amendment |
Initial notification
|
| 3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
| a) |
Name |
Scapa Group plc
|
| b) |
LEI
|
213800QIPVTK5ES5UU36 |
| 4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
|
|
| a) |
Description of financial instrument, type of instrument |
Ordinary Shares of 5p each |
|
|
Identification Code
|
GB0007281198 |
| b) |
Nature of the transaction |
Grant of share option
|
| c) |
Price(s) and volume(s)
|
300,172 Ordinary Shares Exercise price 0p |
| d) |
Aggregated information - Aggregated volume - Price |
n/a |
| e) |
Date of the transaction |
16 September 2020
|
| f) |
Place of the transaction |
Off Market
|
| 1 |
Details of the person discharging managerial responsibilities / person closely associated
|
|
| a) |
Name |
John Petreanu
|
| 2 |
Reason for the notification
|
|
| a) |
Position / status |
President, Healthcare
|
| b) |
Initial notification / amendment |
Initial notification
|
| 3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
| a) |
Name |
Scapa Group plc
|
| b) |
LEI
|
213800QIPVTK5ES5UU36 |
| 4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
|
|
| a) |
Description of financial instrument, type of instrument |
Ordinary Shares of 5p each |
|
|
Identification Code
|
GB0007281198 |
| b) |
Nature of the transaction |
Grant of share option
|
| c) |
Price(s) and volume(s)
|
254,113 Ordinary Shares Exercise price 0p |
| d) |
Aggregated information - Aggregated volume - Price |
n/a |
| e) |
Date of the transaction
|
16 September 2020 |
| f) |
Place of the transaction
|
Off Market |
| 1 |
Details of the person discharging managerial responsibilities / person closely associated
|
|
| a) |
Name |
Brett Pollard
|
| 2 |
Reason for the notification
|
|
| a) |
Position / status |
MD, Global Corp Development & Strategy
|
| b) |
Initial notification / amendment |
Initial notification
|
| 3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
| a) |
Name |
Scapa Group plc
|
| b) |
LEI
|
213800QIPVTK5ES5UU36 |
| 4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
|
|
| a) |
Description of financial instrument, type of instrument |
Ordinary Shares of 5p each |
|
|
Identification Code
|
GB0007281198 |
| b) |
Nature of the transaction |
Grant of share option
|
| c) |
Price(s) and volume(s)
|
75,043 Ordinary Shares Exercise price 0p |
| d) |
Aggregated information - Aggregated volume - Price |
n/a |
| e) |
Date of the transaction
|
16 September 2020 |
| f) |
Place of the transaction
|
Off Market |
| 1 |
Details of the person discharging managerial responsibilities / person closely associated
|
|
| a) |
Name |
Wendy Baker
|
| 2 |
Reason for the notification
|
|
| a) |
Position / status |
Group General Counsel and CoSec
|
| b) |
Initial notification / amendment |
Initial notification
|
| 3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
| a) |
Name |
Scapa Group plc
|
| b) |
LEI
|
213800QIPVTK5ES5UU36 |
| 4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
|
|
| a) |
Description of financial instrument, type of instrument |
Ordinary Shares of 5p each |
|
|
Identification Code
|
GB0007281198 |
| b) |
Nature of the transaction |
Grant of share option
|
| c) |
Price(s) and volume(s)
|
145,798 Ordinary Shares Exercise price 0p |
| d) |
Aggregated information - Aggregated volume - Price |
n/a |
| e) |
Date of the transaction
|
16 September 2020 |
| f) |
Place of the transaction |
Off Market
|
For further information:
Scapa Group plc:
Wendy Baker +44 (0) 161 301 7400
Company Secretary
Numis Securities Limited: +44 (0) 20 7260 1000
Mark Lander/Freddie Barnfield
(Joint Broker/Nominated Adviser)
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.